HOTH
Hoth Therapeutics Inc
NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY
$0.71
-2.70% today
Updated 2026-04-29
Market cap
$13.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$0 – $2
Volume
3.1M
Hoth Therapeutics Inc (HOTH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-191.40%
ROA
-100.90%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-2.02M | — | — | — |
| 2018 | $0.00 | $-2.50M | — | — | — |
| 2019 | $0.00 | $-7.69M | — | — | — |
| 2020 | $0.00 | $-7.20M | — | — | — |
| 2021 | $0.00 | $-14.31M | — | — | — |
| 2022 | $0.00 | $-11.37M | — | — | — |
| 2023 | $0.00 | $-7.85M | — | — | — |
| 2024 | $0.00 | $-8.19M | — | — | — |
| 2025 | $0.00 | $-12.47M | — | — | — |